|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Serum anti-Müllerian hormone is a better predictor of ovarian response than FSH and age in IVF patients with endometriosis|
|Ji Hee Yoo, Sun Hwa Cha, Chan Woo Park, Jin Young Kim, Kwang Moon Yang, In Ok Song, Mi Kyoung Koong, Inn Soo Kang, Hye Ok Kim|
Clin Exp Reprod Med. 2011;38(4):222-227. Published online December 31, 2011
Serum anti-Müllerian hormone is a better predictor of ovarian response than FSH and age in IVF patients with endometriosis
Anti-mullerian hormone (AMH), antral follicle count (AFC) AND age predict IVF outcomes significantly better than follicle stimulating hormone (FSH)
Antral follicle count determines poor ovarian response better than anti-müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles
Anti mullerian hormone (AMH) levels at the onset of IVF predict outcome better than patient age or prior FSH levels
O284 COMPARISON OF OVARIAN RESERVE MEASURED BY SERUM ANTI-MÜLLERIAN HORMONE IN WOMEN WITH AND WITHOUT OVARIAN ENDOMETRIOSIS
Ovarian response prediction in controlled ovarian stimulation for IVF using anti-Müllerian hormone in Chinese women
Serum anti-Müllerian hormone levels as a predictor of the ovarian response and IVF outcomes
Is anti-mullerian hormone (AMH) a predictor of ovarian response in infertile women < 35 years of age with an elevated day 3 FSH level?
Maximal historical FSH is a better predictor of cycle outcome than the baseline FSH for the IVF cycle
Anti-mullerian hormone (AMH), Inhibin B, follicle stimulating hormone (FSH) and antral follicle count (AFC); which one is the best predictor of ovarian response in assisted reproductive technology?